Effect of continuous injection of pain relief medication around nerves after amputations of the leg
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: I739- Peripheral vascular disease, unspecified
- Registration Number
- CTRI/2023/07/055331
- Lead Sponsor
- JIPMER Intramural fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Adult patients (Age >= 18 years) undergoing elective or emergency major lower limb amputations
1.Patients undergoing hip disarticulation, and hindquarter amputation.
2.Patients who have an allergy to bupivacaine
3.Patients are expected to be requiring sedation or ventilatory support for more than 24 hours.
4.Patients undergoing revision amputation who have been previously recruited into the study.
5.Patients undergoing bilateral amputations.
6.Patients in whom the appropriate nerve could not be identified.
7.Patients undergoing Guillotine amputation.
8.Patient denying consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the decrease in patientâ??s post-operative opioid requirement in those undergoing major lower limb amputation and receiving continuous perineural infusion of bupivacaine for three days compared to those receiving standard careTimepoint: Measured every 6h for 72h
- Secondary Outcome Measures
Name Time Method To determine and compare the postoperative continuous perineural infusion of Bupivacaine and standard management after major lower limb amputation for incidence of catheter-related complications (brocade, slippage, wound infections). <br/ ><br>Timepoint: duration of hospital stay;To determine and compare the postoperative continuous perineural infusion of Bupivacaine and standard management after major lower limb amputation for incidence of Phantom limb painTimepoint: 3 months post op;To determine and compare the postoperative continuous perineural infusion of Bupivacaine and standard management after major lower limb amputation for postoperative mean pain score assessed using the visual analog scale (VAS) for three days in both groups. <br/ ><br>Timepoint: 3 days